Thermo Fisher Scientific Signs Exclusive Global Distribution Agreement with NewLab Engineering for Forensic Sample Processing Technology

CARLSBAD, Calif. -- Thermo Fisher Scientific has signed an agreement with NewLab Engineering, a subsidiary of COPAN Italia, for the exclusive global rights to distribute Card Processing Automation (CPA) technology, which is designed to prepare DNA samples for human identification in forensic, paternity and research laboratories. Under the agreement, Thermo Fisher is the sole distributor [...]

Apollo Hospitals Launches Strand’s Clinical Genomic Tests for Personalized Medicine

Hyderabad -- Apollo Hospitals announced the launch of cutting-edge clinical genomic tests from the Strand Center for Genomics and Personalized Medicine, a part of Strand Life Sciences across its hospital network. These tests in oncology, cardiovascular, heritable eye diseases and rare genetic disorders shall be integrated into clinical practice by Apollo’s subsidiary, Sapien Biosciences in [...]

Simulations Plus to Acquire Cognigen Corporation

LANCASTER, Calif.-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has entered into an Agreement and Plan of Merger (the “Agreement”) with Cognigen Corporation of Buffalo, New York. Pursuant to the Agreement, upon closing, Cognigen will become a wholly-owned subsidiary of Simulations [...]

QIAGEN adds promising genomic biomarkers for assessing prognosis in treatment of blood cancers to Personalized Healthcare pipeline

HILDEN, Germany, and MARSEILLE, France -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has acquired an exclusive global license to the biomarker SF3B1 from the University of Tokyo. SF3B1 is believed to play a critical role in the prognosis of patients with myelodysplastic syndromes (MDS), a group of hematological cancers in [...]

Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery

SAN DIEGO -- Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine and clinical trials. Cypher Genomics and Illumina will jointly offer pharmaceutical companies, through Illumina's sales force, a solution including Illumina's market leading sequencing [...]

GENALICE and deCODE Genetics enter into a partnership for population wide genomic analysis

GENALICE announced today it is partnering with deCODE Genetics to facilitate the large-scale testing of its unique DNA data processing software solution, GENALICE MAP. After a first successful round of evaluating GENALICE MAP on speed and quality, both parties agreed to extend the evaluation to include up to 10,000 full human genomes. Population wide analysis [...]

Unique Flow Alarm Technology Secures SERVOTOUGH FluegasExact for Gasco Combustion Analysis

Crowborough, UK -- Servomex, the world leader in gas analysis technology, continues to win new converts to its acclaimed SERVOTOUGH FluegasExact (2700) high performance combustion gas analyzer. Gasco, the natural gas processing company of the Abu Dhabi National Oil Company (ADNOC) Group responsible for processing onshore natural gas and associated gas from onshore oil production, [...]

VICAM’s Afla-V Lateral Flow Strip Test Receives USDA-GIPSA Certification

MILFORD, Mass.-- Waters Corporation (NYSE:WAT) today announced VICAM®, A Waters® Business, received USDA-GIPSA (Grain Inspection, Packers & Stockyards Administration) certification for its Afla-V™ lateral flow strip test for the quantitative analysis of total aflatoxins in corn. “We are pleased to obtain USDA-GIPSA certification for the Alfa-V. This enables official USDA export laboratories and USDA-licensed grain [...]

Teledyne Technologies Appoints Jane Sherburne to Board of Directors Contacts

THOUSAND OAKS, California -- Teledyne Technologies Incorporated (NYSE:TDY) announced today the appointment of Jane C. Sherburne, former Senior Executive Vice President, General Counsel and Corporate Secretary of The Bank of New York Mellon Corporation, to the company’s board of directors, effective August 1, 2014. The addition of Sherburne raises the number of board members to [...]

Dr. Meir Silver Joins Aspect Imaging as New Director, Pre-Clinical Research

SHOHAM, Israel -- Aspect Imaging, the world leading developer of high-performance compact permanent magnets, announced that Meir Silver, PhD has joined Aspect's management team as the new Director, Pre-clinical research. Dr. Silver, in his new role will lead Aspect Imaging's pre-clinical platform technology and commercialization initiatives and will continue to create new application opportunities upon [...]

Access IBO on Knowledge Center